The overall objective of the research is to identify and exploit novel immune cell subsets and drug targets that enables the immune system to efficiently eradicate cancer cells, and to translate those innovation into novel clinical strategies. In this particular project we perform an unbiased transcriptomic analysis using single cell RNAseq, to outline immune cell subsets and their respective transcriptomic profile, in bladder tumors. An bioinformatical pipeline to analyse single cell RNAseq data has been developed and will be employed for the analysis. The main focus of the project is T-cells and cells that regulate T-cell activity, such as myeloid cells.